# A Study to Evaluate the Efficacy and Safety of LNK01004 Ointment in Adults With Atopic Dermatitis

> **NCT07071610** · PHASE2 · COMPLETED · sponsor: **Lynk Pharmaceuticals Co., Ltd** · enrollment: 75 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** LNK01004 ointment 0.3%
- **DRUG:** LNK01004 ointment 1.0%
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT07071610
- **Lead sponsor:** Lynk Pharmaceuticals Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-18
- **Primary completion:** 2025-07-24
- **Final completion:** 2025-07-24
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2026-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07071610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07071610, "A Study to Evaluate the Efficacy and Safety of LNK01004 Ointment in Adults With Atopic Dermatitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07071610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*